Cargando…
Refocusing Neuroprotection in Cerebral Reperfusion Era: New Challenges and Strategies
Pathophysiological processes of stroke have revealed that the damaged brain should be considered as an integral structure to be protected. However, promising neuroprotective drugs have failed when translated to clinical trials. In this review, we evaluated previous studies of neuroprotection and fou...
Autores principales: | Xiong, Xiao-Yi, Liu, Liang, Yang, Qing-Wu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926527/ https://www.ncbi.nlm.nih.gov/pubmed/29740385 http://dx.doi.org/10.3389/fneur.2018.00249 |
Ejemplares similares
-
Melatonin: a promising neuroprotective agent for cerebral ischemia-reperfusion injury
por: Tozihi, Majid, et al.
Publicado: (2023) -
Neuroprotectants in the Era of Reperfusion Therapy
por: Chamorro, Ángel
Publicado: (2018) -
Refocusing on work-based hazards for the anaesthesiologist in a post-pandemic era
por: Nelson, Olivia, et al.
Publicado: (2023) -
Neuroprotective effects of SMADs in a rat model of cerebral ischemia/reperfusion
por: Liu, Fang-fang, et al.
Publicado: (2015) -
Neuroprotective Effect of β-Caryophyllene on Cerebral Ischemia-Reperfusion Injury via Regulation of Necroptotic Neuronal Death and Inflammation: In Vivo and in Vitro
por: Yang, Mei, et al.
Publicado: (2017)